Antibody-Drug Conjugates: A Targeted Approach to Cancer Treatment
Cancer remains one of the most formidable challenges in medicine, with its treatment often involving a delicate balance between eradicating diseased cells and preserving healthy ones. Antibody-drug conjugates (ADCs) represent a promising, targeted approach that seeks to bridge this gap. By combining the specificity of antibodies with the potency of cytotoxic drugs, ADCs aim to […]
4 minute read